| Date Filed | Type | Description |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2023 |
SC 13G/A
| Cullen Michael T. reports a 3.3% stake in Panbela Therapeutics, Inc. |
| 10/06/2022 |
4
| Cullen Michael T. (10% Owner) has filed a Form 4 on Panbela Therapeutics, Inc.|
Txns:
| Bought 165,000 shares
@ $0
Bought 247,000 warrants
@ $0.3, valued at
$74.1k
|
|
| 02/14/2022 |
SC 13G/A
| Cullen Michael T. reports a 6.3% stake in Panbela Therapeutics, Inc. |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
5/A
| Form 5/A - Annual statement of changes in beneficial ownership of securities: [Amend] |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/01/2020 |
4
| Cullen Michael T. (Exec. Chairman, Pres. & CEO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Bought 10,000 shares
@ $0
Bought 10,000 warrants
@ $4.54, valued at
$45.4k
|
|
| 09/01/2020 |
4/A
| Cullen Michael T. (Exec. Chairman, Pres. & CEO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Bought 10,000 shares
@ $0 |
|
| 06/26/2020 |
4
| Cullen Michael T. (Exec. Chairman, Pres. & CEO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.98, valued at
$249k
|
|
| 05/27/2020 |
4
| Cullen Michael T. (Exec. Chairman, Pres. & CEO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Bought 10,000 shares
@ $0
Bought 10,000 warrants
@ $6, valued at
$60k
|
|
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/26/2019 |
4
| Cullen Michael T. (Exec. Chairman, Pres. & CEO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Granted 30,000 options to buy
@ $5, valued at
$150k
|
|
| 09/04/2019 |
4
| Cullen Michael T. (Exec. Chairman, Pres. & CEO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Bought 30,000 shares
@ $0
Bought 30,000 warrants
@ $4, valued at
$120k
|
|
| 07/02/2019 |
4
| Cullen Michael T. (Exec. Chairman, Pres. & CEO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Converted 10,495 shares
@ $0
Converted 35,000 convertible notes
@ $3.5, valued at
$122.5k
|
|
| 05/23/2019 |
4
| Cullen Michael T. (Exec. Chairman, Pres. & CEO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Granted 43,300 options to buy
@ $2.95, valued at
$127.7k
Granted 112,800 options to buy
@ $2.95, valued at
$332.8k
|
|
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/03/2019 |
4
| Cullen Michael T. (Exec. Chairman, Pres. & CEO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Bought 35,000 convertible notes
@ $0
Bought 20,000 warrants
@ $4.5, valued at
$90k
|
|
| 03/01/2018 |
4
| Cullen Michael T. (Executive Chairman) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Granted 100,000 options to buy
@ $8.1, valued at
$810k
|
|
| 02/22/2018 |
4
| Cullen Michael T. (Executive Chairman) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Bought 5,000 shares
@ $0
Bought 5,000 warrants
@ $5, valued at
$25k
|
|
| 02/14/2017 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/28/2016 |
4
| Cullen Michael T. (Executive Chairman) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Bought 50,000 shares
@ $0
Bought 25,000 warrants
@ $1.5, valued at
$37.5k
|
|